BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30446355)

  • 21. Predictors of Long-Term Mortality in Older Patients Hospitalized for Acutely Decompensated Heart Failure: Clinical Relevance of Natriuretic Peptides.
    Passantino A; Guida P; Lagioia R; Ammirati E; Oliva F; Frigerio M; Scrutinio D
    J Am Geriatr Soc; 2017 Apr; 65(4):822-826. PubMed ID: 27889914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
    Mentz RJ; Fiuzat M; Wojdyla DM; Chiswell K; Gheorghiade M; Fonarow GC; O'Connor CM
    Eur J Heart Fail; 2012 Apr; 14(4):395-403. PubMed ID: 22302663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
    Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
    Staszewsky L; Wong M; Masson S; Barlera S; Carretta E; Maggioni AP; Anand IS; Cohn JN; Tognoni G; Latini R;
    J Card Fail; 2007 Dec; 13(10):797-804. PubMed ID: 18068611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study.
    Kaszuba E; Odeberg H; Råstam L; Halling A
    BMC Fam Pract; 2018 Nov; 19(1):178. PubMed ID: 30474547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease.
    Kwon BJ; Kim DB; Jang SW; Yoo KD; Moon KW; Shim BJ; Ahn SH; Cho EJ; Rho TH; Kim JH
    Eur J Heart Fail; 2010 Dec; 12(12):1339-44. PubMed ID: 20861127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study.
    Wang WH; Cheng CC; Mar GY; Wei KC; Huang WC; Liu CP
    Heart Vessels; 2019 Jul; 34(7):1158-1167. PubMed ID: 30680495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
    Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
    Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute heart failure with accompanying chronic obstructive pulmonary disease: should we focus on beta blockers?
    Ege MR; Guray U; Guray Y; Yilmaz MB; Yucel O; Zorlu A; Tandogan I
    Herz; 2012 Nov; 37(7):796-800. PubMed ID: 22699995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both.
    Crisafulli E; Sartori G; Vianello A; Busti F; Nobili A; Mannucci PM; Girelli D;
    Intern Emerg Med; 2023 Mar; 18(2):523-534. PubMed ID: 36773107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentric study on the beta-blocker use and relation with exacerbations in COPD.
    Puente-Maestu L; Calle M; Ortega-González A; Fuster A; González C; Márquez-Martín E; Marcos-Rodriguez PJ; Calero C; Rodríguez-Hermosa JL; Malo de Molina R; Aburto M; Sobradillo P; Alcázar B; Tirado-Conde G;
    Respir Med; 2014 May; 108(5):737-44. PubMed ID: 24635914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial.
    Canepa M; Temporelli PL; Rossi A; Rossi A; Gonzini L; Nicolosi GL; Staszewsky L; Marchioli R; Maggioni AP; Tavazzi L;
    Cardiology; 2017; 136(2):128-137. PubMed ID: 27618363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-Blockers are Associated with Decreased In-Hospital Mortality and Stroke in Acute Decompensated Heart Failure: Findings from a Retrospective Analysis of a 22-Year Registry in the Middle East (1991-2013).
    Abi Khalil C; Al Suwaidi J; Singh R; Asaad N; Abushahba G; Kunju U; Al Qahtani A; AlBinali HA
    Curr Vasc Pharmacol; 2017; 15(1):77-83. PubMed ID: 27550053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality.
    Mascarenhas J; Azevedo A; Bettencourt P
    Curr Opin Pulm Med; 2010 Mar; 16(2):106-11. PubMed ID: 20042977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic obstructive pulmonary disease and long-term mortality in elderly subjects with chronic heart failure.
    Testa G; Cacciatore F; Bianco A; Della-Morte D; Mazzella F; Galizia G; Gargiulo G; Curcio F; Liguori I; Sabusco A; Rengo F; Bonaduce D; Abete P
    Aging Clin Exp Res; 2017 Dec; 29(6):1157-1164. PubMed ID: 28224475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.
    Tavazzi L; Swedberg K; Komajda M; Böhm M; Borer JS; Lainscak M; Robertson M; Ford I;
    Int J Cardiol; 2013 Dec; 170(2):182-8. PubMed ID: 24225201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
    Sessa M; Mascolo A; Mortensen RN; Andersen MP; Rosano GMC; Capuano A; Rossi F; Gislason G; Enghusen-Poulsen H; Torp-Pedersen C
    Eur J Heart Fail; 2018 Mar; 20(3):548-556. PubMed ID: 29159953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
    Du Q; Sun Y; Ding N; Lu L; Chen Y
    PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction.
    Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Frigerio M
    J Clin Epidemiol; 2018 Nov; 103():31-39. PubMed ID: 30009940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.
    Bucci T; Romiti GF; Shantsila A; Teo WS; Park HW; Shimizu W; Corica B; Proietti M; Tse HF; Chao TF; Frost F; Lip GYH;
    J Am Heart Assoc; 2024 Apr; 13(7):e032785. PubMed ID: 38533983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.